• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Efficacy of liver transplantation for acute hepatic failure: a single-center experience

    2011-07-05 12:59:32XianJieShiHongBinXuWenBinJiYuRongLiangWeiDongDuanLeiHeMingJunWangandZhiMingZhao

    Xian-Jie Shi, Hong-Bin Xu, Wen-Bin Ji, Yu-Rong Liang, Wei-Dong Duan, Lei He, Ming-Jun Wang and Zhi-Ming Zhao

    Beijing, China

    Efficacy of liver transplantation for acute hepatic failure: a single-center experience

    Xian-Jie Shi, Hong-Bin Xu, Wen-Bin Ji, Yu-Rong Liang, Wei-Dong Duan, Lei He, Ming-Jun Wang and Zhi-Ming Zhao

    Beijing, China

    BACKGROUND:Acute hepatic failure (AHF) is a devastating clinical syndrome with a high mortality rate. The outcome of AHF varies with etiology, but liver transplantation (LT) can significantly improve the prognosis and survival rate of such patients. This study aimed to detect the role of LT and artificial liver support systems (ALSS) for AHF patients and to analyze the etiology and outcome of patients with this disease.

    METHODS:A retrospective analysis was made of 48 consecutive patients with AHF who fulfilled the Kings College Criteria for LT at our center. We analyzed and compared the etiology, outcome, prognosis, and survival rates of patients between the transplantation (LT) group and the non-transplantation (N-LT) group.

    RESULTS:AHF was due to viral hepatitis in 25 patients (52.1%; hepatitis B virus in 22), drug or toxic reactions in 14 (29.2%; acetaminophen in 6), Wilson disease in 4 (8.3%), unknown reasons in 3 (6.3%), and miscellaneous conditions in 2 (4.2%). In the LT group, 36 patients (7 underwent living donor LT, and 29 cadaveric LT) had an average model for endstage liver disease score (MELD) of 35.7. Twenty-eight patients survived with good graft function after a follow-up of 27.3± 4.5 months. During the waiting time, 6 patients were treated with ALSS and 2 of them died during hospitalization. The 30-day, 12-month, and 18-month survival rates were 77.8%, 72.2%, and 66.7%, respectively. In the N-LT group, 12 patients had an average MELD score of 34.5. Four patients were treated with ALSS and all died during hospitalization. The 90-day and 1-year survival rates were only 16.7% and 8.3%, respectively.

    CONCLUSIONS:Hepatitis is the most prominent cause of AHF at our center. Most patients with AHF, who fulfill the Kings College Criteria for LT, did not survive longer without LT. ALSS did not improve the prognosis of AHF patients, but may extend the waiting time for a donor. Currently, LT is still the most effective way to improve the prognosis of AHF patients.

    (Hepatobiliary Pancreat Dis Int 2011; 10: 369-373)

    acute hepatic failure; liver transplantation; arti ficial liver support; prognosis; survival rate; etiology

    Introduction

    Acute hepatic failure (AHF) is a severe condition, which often affects young persons and is associated with a high mortality rate. Moreover, the outcome of AHF varies etiologically and geographically; however, the prognosis of this disorder improves dramatically after liver transplantation (LT). The most widely accepted definition of AHF includes evidence of coagulation abnormality, which is typically determined by the prothrombin time (prothrombin index <40% or international normalized ratio ≥1.5), and any degree of mental alteration (encephalopathy) in patients without pre-existing cirrhosis or with an illness of <26 weeks duration. Patients with Wilson disease, verticallyacquired HBV, or autoimmune hepatitis may be included in spite of the possibility of cirrhosis, if their disease is recognized for <26 weeks.[1]

    This catastrophic illness can progress rapidly resulting in the placement of the patient in a coma and/or death from cerebral edema or multi-organ dysfunction. The reported survival rate of patients with AHF is less than 15% before LT, while the overall short-term survival rate after LT is more than 65%.[2]The present study was undertaken to assess the roleof LT and artificial liver support system (ALSS) in the treatment of AHF patients, and to analyze the etiology of the disease and the outcome of treatment at our center.

    Methods

    We retrospectively reviewed 48 consecutive patients with AHF treated at our center from March 2005 to June 2009, who fulfilled the Kings College Criteria for LT. AHF was diagnosed by clinical, analytical, and histological results. Etiology of the disease, age and sex of the patients, MELD score, perioperative complications, artificial liver support, continuous renal replacement therapy (CRRT), waiting time, causes of death, and survival time were recorded and analyzed. Informed consent was obtained from the patients or their relatives before the study. The study was approved by the Ethics Committee of the General Hospital of PLA.

    General information

    Forty-eight patients (20 males and 28 females) were divided into two groups: a transplantation (LT) group of 36 patients, who had undergone LT, and a nontransplantation (N-LT) group of 12, who had not. The average age of the patients was 34.1±4.9 years, and the MELD score was 35.2±7.9. In the LT group, 6 patients were given ALSS, 6 were given CRRT before surgery, and 6 were given CRRT after surgery. In the N-LT group, 4 patients were given ALSS and 2 were given CRRT (Table 1).

    Etiology

    AHF was due to viral hepatitis in 25 patients (52.1%; hepatitis B virus in 22 patients), drug or toxic reactions in 14 (29.2%; acetaminophen in 6), Wilson disease in 4 (8.3%), unknown reasons in 3 (6.3%), and miscellaneous conditions in 2 (4.2%) (Fig.1).

    Table 1. General information of patients in two groups before operation

    Treatment and follow-up

    Seven patients underwent living donor LT, and 29 received a cadaveric whole liver. Thirty-four pairs of donors and recipients had the same ABO blood type, while the other two pairs were type-B recipients of type-O donors. Other operative data are shown in Table 2. Immunosuppression was based on a regimen of FK506, MMF, and prednisone in all patients. Other than LT, the medical treatments used in both groups were the same, including liver protection, anti-infection, nutritional support and anti-hepatic encephalopathy. The follow-up interval was from the date of diagnosis to death or December 2010.

    Statistical analysis

    Data were analyzed on a CHISS system (Windows version 3.0.0.21). Baseline data were presented as mean± SD. Actuarial survival rates were calculated by the Kaplan-Meier method.

    Results

    During the period of hospitalization, 19 patients died of brain edema and refractory intracranial hypertension, multi-organ failure (MOF), sepsis, renal failure, coagulation disorders (intracranial hemorrhage, upper digestive tract hemorrhage), acute respiratory distress syndrome, and primary graft non-function.

    Fig. 1. Causes of 48 patients with AHF. LT: transplantation group; N-LT: non-transplantation group; AIH: autoimmune hepatitis; AHF: acute hepatic failure.

    Table 2. Operative information

    Fig. 2. The survival rate was significantly greater in the LT group than in the N-LT group (P<0.001). LT: transplantation group; N-LT: non-transplantation group.

    In the LT group, 8 patients died during their hospitalization, while 28 patients survived and showed good graft function during the median follow-up time of 27.3±4.5 months. The average waiting time for LT was 78±16 hours. During the waiting period, 6 patients were treated with ALSS and 2 of them died after LT. After surgery, 6 patients were given CRRT, but only 2 of these patients survived. Five patients who exhibited vascular or biliary complications recovered after interventional or surgical therapy. The 30-day, 12-month, and 18-month survival rates were 77.8%, 72.2% and 66.7%, respectively. In the N-LT group, only one patient survived longer. Four patients were given ALSS, but all died during the period of hospitalization. The 90-day and 1-year survival rates were only 16.7% and 8.3%, respectively. In all 29 long-term surviving patients, 19 experienced a good quality of life and resumed their normal activities. The survival rate was significantly greater in the LT group than in the N-LT group (χ2=14.846, P<0.001, Fig. 2). In patients who received ALSS, the level of serum bilirubin was significantly reduced, in addition to a marked regression of pruritus. Moreover, hepatic encephalopathy was also improved and no severe events occurred in patients receiving ALSS.

    Discussion

    AHF is a condition, which can progress rapidly with daily changes in consciousness and coagulation. Because AHF may result in such lethal complications as MOF, hepatic encephalopathy, and coagulation disorders, immediate etiological identification and intensive care are crucial. LT may remarkably improve the prognosis of patients with AHF;[3]however, not all patients with AHF should undergo transplantation. Because of the shortage of organ donors and the growing demand, patients should be evaluated carefully for LT.

    The most frequently accepted criteria for LT in AHF patients are the Kings College Hospital criteria[4]and the Clichy criteria,[5]even though these criteria were formulated a decade ago. Compared to the Kings College Hospital criteria proposed by O'Grady, validation studies of the Clichy criteria are scarce, and its derivation was from a cohort of patients with AHF resulting from a single condition.[6]Hence, in our study, we used the Kings College Hospital criteria, which differentiate patients with acetaminophen-induced hepatotoxicity from those with other causes (nonacetaminophen-induced hepatotoxicity) of AHF,[6,7]to evaluate whether LT is needed or not.

    Despite the improvement of therapeutic modalities in intensive care medicine, AHF is still an intractable condition with a high mortality rate.[8]In our patients, the most common causes of death were MOF, renal failure, sepsis, brain edema, and refractory intracranial hypertension. Although we took many measures such as CRRT, ALSS, and medical treatments to prevent or remedy these complications, many patients died.

    In our experience, we found several important factors to consider when caring for patients with AHF. First, the maintenance of hemodynamic stability is a key for preventing renal failure. Although renal failure alone rarely leads to death, once it occurs the patient's prognosis is poor.[9]After surgery, 6 patients in our study required CRRT, but only 2 survived. Second, the pathogenesis of brain edema and refractory intracranial hypertension is poorly understood, but its incidence and severity are closely associated with hepatic encephalopathy. In patients with hepatic encephalopathy at stagesito II, brain edema is rare; yet patients at stage III exhibit a risk of 25%-35% for developing brain edema and the risk to patients at stage IV increases to 65%-75% or more.[10,11]These increased risks highlight the importance of monitoring intracranial pressure in patients with grade III/IV encephalopathy. Therefore, moderate hypothermia might be a promising treatment for patients with refractory intracranial hypertension,[12]other measures, such as head elevation, plasma colloid elevation, and/or application of mannitol may also be effective treatments.[13]Third, it is of utmost importance to immediately address any observed infections by shortening the time for the patient on mechanical ventilation, removing or reducing the factors which aggravate or induce infections, and adjusting doses of anti-infection agents.

    AHF is a fatal condition that remains poorly understood, but defining the etiology is of great importance in predicting the patient's prognosis.[14]Theetiology of AHF is significantly different in geography and times. In east Asia and developing countries, AHF is mainly due to viral infections, such as hepatitis B, A, and E. In the United States and Western Europe, the incidence of virus-induced disease has declined substantially in recent years, with most cases now arising from drug-induced liver injury.[15]In Bangladesh, acute HEV infections are the leading cause of AHF.[16]In our study, more than half of the patients with AHF were attributed to hepatitis (19 patients in the LT group and 6 in the N-LT group) infections, especially hepatitis B (45.8%), and may be one of the reasons for the higher mortality in our N-LT group.

    The lack of donor livers and other transplant-related problems leads to the death of many patients during the waiting period. In the United States, over 30% of patients listed for emergency LT will die while waiting for a graft.[17]Besides standard medical therapy, ALSS or hepatocyte transplantation is currently used for treating AHF.[18-20]In this study, we used the molecular adsorbent recirculation system, ALSS, which is an extracorporeal artificial liver support system that contains no biologic components. ALSS can remove endotoxins, bilirubin, and other toxic substances from the body, add a variety of plasma coagulation factors, treat hyperbilirubinemia, and improve blood coagulation and consciousness of patients with hepatic encephalopathy. In our LT group, 6 patients were treated with ALSS during the waiting time and 2 of them died during the period of hospitalization. In the N-LT group, 4 patients were treated with ALSS and all died during hospitalization. Apparently, ALSS may extend the waiting time for a donor and serves as a bridge for patients with AHF and needing a LT, but it does not improve the mortality and prognosis of AHF patients.[21]Of course, the use of ALSS as a therapeutic option is still under investigation and lacks proven longterm successful results, thus making LT the final and most effective therapy.

    At times, AHF patients have to receive an ABO-incompatible donor liver to save their lives.[22]It is reported that ABO-incompatibility has no significant impact on patient survival. However, graft survival is significantly impaired by hyperacute rejection (20%), vascular thrombosis, and biliary injury (56%).[23]In our study, there were two type B recipients from type O donors, and both exhibited long-term survival. This result showed that even ABO-incompatible liver grafts can be used in the emergency, life-saving treatment of patients with AHF.

    In summary, unlike in developed countries, viral infections, especially hepatitis B, were the most prominent causes of AHF in this study. In the N-LT group, all but one patient died. ALSS did not improve the prognosis of AHF patients, but did extend the waiting time for a donor. The use of ABO-incompatible liver grafts is a possible life-saving method for the emergency treatment of patients with AHF. Most patients with AHF, who fulfilled the Kings College Criteria for LT, would not survive longer if LT is not performed. In spite of great improvement in medication, LT is still currently the most effective way for improving the prognosis of AHF patients. Because of the limitations of LT, final decisions for LT should depend upon rapid diagnosis and accurate prognostic evaluation. Although new therapies for AHF are still being investigated, alternative treatment modalities also require further study.

    Funding:None.

    Ethical approval:The study was approved by the Ethics Committee of the General Hospital of PLA, China.

    Contributors:SXJ proposed and designed the study. SXJ and LYR wrote the first draft. XHB and JWB analyzed the data. All authors contributed to the design and interpretation of the study and to further drafts. SXJ is the guarantor.

    Competing interest:No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

    1 Polson J, Lee WM; American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology 2005;41:1179-1197.

    2 Ostapowicz G, Fontana RJ, Schi?dt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-954.

    3 Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop. Hepatology 2008;47:1401-1415.

    4 O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445.

    5 Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 1995;222:109-119.

    6 Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol 2004;40:192-197.

    7 Riordan SM, Williams R. Use and validation of selection criteria for liver transplantation in acute liver failure. Liver Transpl 2000;6:170-173.

    8 Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R, N?ldge-Schomburg G. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol 2001;12:S75-82.

    9 Murphy EJ, Davern TJ, Shakil AO, Shick L, Masharani U, Chow H, et al. Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group. Dig Dis Sci 2000;45:549-553.

    10 Vaquero J, Chung C, Cahill ME, Blei AT. Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Liver Dis 2003;23:259-269.

    11 Cordoba J, Blei AT. Cerebral edema and intracranial pressure monitoring. Liver Transpl Surg 1995;1:187-194.

    12 Detry O, De Roover A, Honore P, Meurisse M. Brain edema and intracranial hypertension in fulminant hepatic failure: pathophysiology and management. World J Gastroenterol 2006;12:7405-7412.

    13 Blei AT. Monitoring cerebral blood flow: a useful clinical tool in acute liver failure? Liver Transpl 2005;11:1320-1322.

    14 MacQuillan G. Predicting outcome in acute liver failure: are we there yet? Liver Transpl 2007;13:1209-1211.

    15 Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 2010;376:190-201.

    16 Mahtab MA, Rahman S, Khan M, Mamun AA, Afroz S. Etiology of fulminant hepatic failure: experience from a tertiary hospital in Bangladesh. Hepatobiliary Pancreat Dis Int 2008;7:161-164.

    17 Lee WM. Acute liver failure in the United States. Semin Liver Dis 2003;23:217-226.

    18 Wu CX, Zou Q, Zhu ZY, Gao YT, Wang YJ. Intrahepatic transplantation of hepatic oval cells for fulminant hepatic failure in rats. World J Gastroenterol 2009;15:1506-1511.

    19 Yagi H, Parekkadan B, Suganuma K, Soto-Gutierrez A, Tompkins RG, Tilles AW, et al. Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure. Tissue Eng Part A 2009;15: 3377-3388.

    20 Pareja E, Cortes M, Bonora A, Fuset P, Orbis F, Lopez R, et al. New alternatives to the treatment of acute liver failure. Transplant Proc 2010;42:2959-2961.

    21 Kjaergard LL, Liu J, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA 2003;289:217-222.

    22 Saliba F, Ichai P, Azoulay D, Habbouchi H, Antonini T, Sebagh M, et al. Successful long-term outcome of ABO-incompatible liver transplantation using antigen-specific immunoadsorption columns. Ther Apher Dial 2010;14:116-123.

    23 Farges O, Kalil AN, Samuel D, Saliba F, Arulnaden JL, Debat P, et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation 1995;59:1124-1133.

    Received September 30, 2010

    Accepted after revision April 18, 2011

    Author Affiliations: Department of Hepatobiliary Surgery (Shi XJ, Xu HB, Ji WB, Liang YR, Duan WD, Heland Zhao ZM), and Department of Anesthesiology (Wang MJ), General Hospital of PLA, Beijing 100853, China

    Xian-Jie Shi, MD, Department of Hepatobiliary Surgery, General Hospital of PLA, Beijing 100853, China (Tel: 86-10-68241383; Email: shixianjie301@yahoo.com.cn)

    ? 2011, Hepatobiliary Pancreat Dis Int. All rights reserved.

    舔av片在线| 99在线视频只有这里精品首页| 国产私拍福利视频在线观看| 久久久久国产精品人妻aⅴ院| 性欧美人与动物交配| av在线播放精品| 亚洲一级一片aⅴ在线观看| 两个人的视频大全免费| 午夜免费男女啪啪视频观看 | 大香蕉久久网| 亚洲av不卡在线观看| 国产精品久久久久久av不卡| 99久久中文字幕三级久久日本| 日本-黄色视频高清免费观看| 看片在线看免费视频| 干丝袜人妻中文字幕| 99国产精品一区二区蜜桃av| 久久久成人免费电影| 99久久九九国产精品国产免费| 别揉我奶头 嗯啊视频| 美女cb高潮喷水在线观看| 亚洲精品粉嫩美女一区| 波多野结衣高清无吗| 亚洲性久久影院| 亚洲精品乱码久久久v下载方式| 卡戴珊不雅视频在线播放| 黑人高潮一二区| 国产三级中文精品| 久久精品国产亚洲av涩爱 | 在线观看午夜福利视频| 久久久久久大精品| 男女下面进入的视频免费午夜| 国产老妇女一区| 国产精品不卡视频一区二区| 色av中文字幕| 在现免费观看毛片| 亚洲av一区综合| 精品一区二区免费观看| 日产精品乱码卡一卡2卡三| 国产精品99久久久久久久久| 日韩欧美国产在线观看| 久99久视频精品免费| 欧美一区二区国产精品久久精品| 国产不卡一卡二| 国内精品美女久久久久久| 不卡视频在线观看欧美| 国产在线精品亚洲第一网站| 色视频www国产| 99riav亚洲国产免费| 久久久精品欧美日韩精品| 久久精品国产亚洲av香蕉五月| 男人舔奶头视频| 亚洲专区国产一区二区| 国产亚洲精品综合一区在线观看| 一卡2卡三卡四卡精品乱码亚洲| 免费观看的影片在线观看| 听说在线观看完整版免费高清| 国产精品久久久久久精品电影| 一区二区三区高清视频在线| 久久久久国产网址| 国内揄拍国产精品人妻在线| 国产精品久久久久久久电影| 国产精品亚洲美女久久久| 久久久a久久爽久久v久久| 99热这里只有是精品在线观看| 卡戴珊不雅视频在线播放| 床上黄色一级片| 99久久精品热视频| 中文字幕av成人在线电影| 白带黄色成豆腐渣| 国产在线男女| 一本精品99久久精品77| 人妻久久中文字幕网| 日韩 亚洲 欧美在线| 亚洲精品久久国产高清桃花| 深爱激情五月婷婷| 久久人人爽人人爽人人片va| 黄片wwwwww| 日本免费一区二区三区高清不卡| 日韩精品中文字幕看吧| 日韩一区二区视频免费看| 直男gayav资源| 性欧美人与动物交配| 午夜精品在线福利| av卡一久久| 乱人视频在线观看| 深夜精品福利| 男人舔女人下体高潮全视频| 国产男靠女视频免费网站| 九九在线视频观看精品| 亚洲图色成人| av女优亚洲男人天堂| 精品乱码久久久久久99久播| 婷婷色综合大香蕉| 成人毛片a级毛片在线播放| 色哟哟哟哟哟哟| 亚洲精品日韩在线中文字幕 | 日本 av在线| 色在线成人网| 22中文网久久字幕| 久久久成人免费电影| 亚洲性夜色夜夜综合| 国产精品三级大全| 色吧在线观看| 最近视频中文字幕2019在线8| 嫩草影院入口| 99国产精品一区二区蜜桃av| 乱人视频在线观看| 久久人人爽人人爽人人片va| 91麻豆精品激情在线观看国产| 五月伊人婷婷丁香| 日韩精品青青久久久久久| 国产精品一区二区性色av| 欧美最新免费一区二区三区| 少妇熟女aⅴ在线视频| 免费av观看视频| 国产探花在线观看一区二区| 国产精品一区二区免费欧美| 亚洲不卡免费看| 特大巨黑吊av在线直播| 成人性生交大片免费视频hd| 禁无遮挡网站| 一级毛片我不卡| 久久6这里有精品| 亚洲性夜色夜夜综合| 噜噜噜噜噜久久久久久91| 精品久久久久久久久av| АⅤ资源中文在线天堂| 久久精品国产清高在天天线| 久久精品夜夜夜夜夜久久蜜豆| 精华霜和精华液先用哪个| 亚洲美女黄片视频| 欧美又色又爽又黄视频| 大型黄色视频在线免费观看| 国产女主播在线喷水免费视频网站 | 亚洲精品在线观看二区| 两个人的视频大全免费| 免费观看在线日韩| 成人亚洲欧美一区二区av| av天堂中文字幕网| 国产精品亚洲美女久久久| 免费av观看视频| 亚洲国产日韩欧美精品在线观看| 日韩欧美在线乱码| 看黄色毛片网站| 亚洲欧美日韩高清在线视频| 国产在线精品亚洲第一网站| 又黄又爽又刺激的免费视频.| 国产aⅴ精品一区二区三区波| 亚洲图色成人| 久久久久精品国产欧美久久久| 最近最新中文字幕大全电影3| 内地一区二区视频在线| 校园春色视频在线观看| 欧美极品一区二区三区四区| 特大巨黑吊av在线直播| 国产精品久久久久久久久免| 极品教师在线视频| 女的被弄到高潮叫床怎么办| 亚洲欧美精品综合久久99| 色av中文字幕| 内地一区二区视频在线| 在线播放国产精品三级| 在线播放国产精品三级| 又爽又黄a免费视频| av在线老鸭窝| 大又大粗又爽又黄少妇毛片口| 欧美最黄视频在线播放免费| av专区在线播放| 波多野结衣巨乳人妻| 一级毛片aaaaaa免费看小| 国产av麻豆久久久久久久| 真人做人爱边吃奶动态| 人人妻人人看人人澡| 国产亚洲精品综合一区在线观看| 欧美高清成人免费视频www| 亚洲国产日韩欧美精品在线观看| 国产午夜精品论理片| 国产探花极品一区二区| 婷婷亚洲欧美| 小说图片视频综合网站| 日本-黄色视频高清免费观看| 亚洲欧美精品自产自拍| 成人av一区二区三区在线看| 久久精品人妻少妇| 自拍偷自拍亚洲精品老妇| 国产精品无大码| 一区福利在线观看| 亚洲综合色惰| 国产av不卡久久| 欧美性猛交╳xxx乱大交人| 嫩草影院入口| 欧美成人精品欧美一级黄| 中文资源天堂在线| 在线观看av片永久免费下载| 久久久久久伊人网av| 免费不卡的大黄色大毛片视频在线观看 | 国产又黄又爽又无遮挡在线| 免费观看精品视频网站| 黄色日韩在线| 变态另类成人亚洲欧美熟女| 国产亚洲精品久久久久久毛片| 午夜福利在线观看免费完整高清在 | 久久草成人影院| 成年av动漫网址| 国产色爽女视频免费观看| 午夜精品一区二区三区免费看| 啦啦啦观看免费观看视频高清| 国产伦精品一区二区三区四那| 在线国产一区二区在线| 欧美人与善性xxx| 少妇高潮的动态图| 国产精品亚洲一级av第二区| 高清午夜精品一区二区三区 | av福利片在线观看| 久久精品91蜜桃| 亚洲电影在线观看av| 一进一出抽搐gif免费好疼| 91午夜精品亚洲一区二区三区| 亚洲精品亚洲一区二区| 亚洲美女黄片视频| 国产一区二区在线观看日韩| 男女下面进入的视频免费午夜| 99久久精品热视频| 菩萨蛮人人尽说江南好唐韦庄 | 国模一区二区三区四区视频| 日本一二三区视频观看| 久久国内精品自在自线图片| 亚洲欧美中文字幕日韩二区| 韩国av在线不卡| 女的被弄到高潮叫床怎么办| 又爽又黄a免费视频| 亚洲三级黄色毛片| 国产精品不卡视频一区二区| 看免费成人av毛片| 国产老妇女一区| 成人毛片a级毛片在线播放| 欧美+亚洲+日韩+国产| av国产免费在线观看| 久久99热这里只有精品18| 国产精品久久久久久精品电影| 99热只有精品国产| 亚洲国产欧美人成| 日韩欧美免费精品| 国模一区二区三区四区视频| 亚洲国产精品成人久久小说 | 国产美女午夜福利| 国产白丝娇喘喷水9色精品| 久久久久免费精品人妻一区二区| 欧美潮喷喷水| 成人精品一区二区免费| 亚洲性久久影院| 变态另类成人亚洲欧美熟女| 色哟哟哟哟哟哟| 日本与韩国留学比较| 少妇丰满av| 国产av不卡久久| 少妇裸体淫交视频免费看高清| 91久久精品国产一区二区成人| 99久国产av精品国产电影| 97超级碰碰碰精品色视频在线观看| 蜜桃久久精品国产亚洲av| 午夜精品一区二区三区免费看| 尾随美女入室| 国产老妇女一区| 男人舔奶头视频| 国产一区二区三区av在线 | 国内揄拍国产精品人妻在线| 免费高清视频大片| 校园人妻丝袜中文字幕| 男人的好看免费观看在线视频| 中文字幕精品亚洲无线码一区| 亚洲久久久久久中文字幕| 欧美潮喷喷水| 久久久久国产网址| 12—13女人毛片做爰片一| 久久国产乱子免费精品| 91麻豆精品激情在线观看国产| 欧美性猛交黑人性爽| av卡一久久| 久久人妻av系列| 亚洲色图av天堂| 国产精品,欧美在线| 亚洲欧美日韩高清专用| 久久人妻av系列| 国产女主播在线喷水免费视频网站 | 久久国产乱子免费精品| 在线观看午夜福利视频| 日韩大尺度精品在线看网址| 97碰自拍视频| 99热只有精品国产| 丝袜美腿在线中文| 99热这里只有是精品在线观看| 精品久久久噜噜| 亚洲经典国产精华液单| 国产精品福利在线免费观看| 哪里可以看免费的av片| 中国美女看黄片| 如何舔出高潮| 亚洲欧美成人精品一区二区| 身体一侧抽搐| 亚洲综合色惰| 一个人免费在线观看电影| 国产91av在线免费观看| 亚洲第一区二区三区不卡| 亚洲自偷自拍三级| 国产精品久久视频播放| 国产精品久久久久久久久免| 日韩在线高清观看一区二区三区| 日本黄色视频三级网站网址| 男女做爰动态图高潮gif福利片| 一个人免费在线观看电影| 久久人人爽人人片av| 美女被艹到高潮喷水动态| 成年女人看的毛片在线观看| 欧美一区二区亚洲| 精品久久久久久久久久免费视频| 亚洲成人久久性| 亚洲av第一区精品v没综合| 国产亚洲欧美98| 免费av观看视频| 嫩草影视91久久| 国产一区二区亚洲精品在线观看| 一本一本综合久久| 精品久久久久久久久久久久久| 国产精品不卡视频一区二区| 日韩欧美 国产精品| 亚洲熟妇中文字幕五十中出| 男人的好看免费观看在线视频| 久久精品国产亚洲av天美| 久久久久国产网址| 亚洲欧美日韩无卡精品| 99九九线精品视频在线观看视频| 51国产日韩欧美| 波多野结衣巨乳人妻| 久久久久久九九精品二区国产| 床上黄色一级片| 简卡轻食公司| av专区在线播放| 国产精品综合久久久久久久免费| 国产av不卡久久| av女优亚洲男人天堂| 日韩大尺度精品在线看网址| 国产成人精品久久久久久| 黑人高潮一二区| 免费看日本二区| 亚洲激情五月婷婷啪啪| 亚洲av免费高清在线观看| 久久亚洲国产成人精品v| 国产精品免费一区二区三区在线| 精品无人区乱码1区二区| 国产极品精品免费视频能看的| 美女xxoo啪啪120秒动态图| 亚洲在线观看片| 精品久久久久久久久亚洲| 老司机影院成人| av在线亚洲专区| 久久人人爽人人爽人人片va| 国产v大片淫在线免费观看| 精品不卡国产一区二区三区| 欧美性猛交╳xxx乱大交人| 国产综合懂色| 12—13女人毛片做爰片一| 听说在线观看完整版免费高清| 热99re8久久精品国产| 成人精品一区二区免费| 99久久久亚洲精品蜜臀av| 免费大片18禁| 欧美一级a爱片免费观看看| 91午夜精品亚洲一区二区三区| 亚洲精品影视一区二区三区av| 国产毛片a区久久久久| 久久精品久久久久久噜噜老黄 | 亚洲最大成人av| 亚洲aⅴ乱码一区二区在线播放| 老司机午夜福利在线观看视频| 观看免费一级毛片| 国产老妇女一区| 国产三级在线视频| 亚洲内射少妇av| 亚洲欧美中文字幕日韩二区| 中出人妻视频一区二区| 人人妻人人看人人澡| 日韩欧美 国产精品| 亚洲国产欧洲综合997久久,| 免费人成视频x8x8入口观看| 男人和女人高潮做爰伦理| 国产色婷婷99| 我的老师免费观看完整版| 少妇被粗大猛烈的视频| 亚洲aⅴ乱码一区二区在线播放| 亚洲av电影不卡..在线观看| 免费无遮挡裸体视频| 国产高清激情床上av| 精品久久久久久久末码| 一本精品99久久精品77| 你懂的网址亚洲精品在线观看 | 麻豆成人午夜福利视频| 一级毛片aaaaaa免费看小| 亚洲经典国产精华液单| 草草在线视频免费看| 男女之事视频高清在线观看| 99热全是精品| 免费一级毛片在线播放高清视频| 精品熟女少妇av免费看| 免费高清视频大片| 18禁裸乳无遮挡免费网站照片| 亚洲一区高清亚洲精品| 熟妇人妻久久中文字幕3abv| 一区二区三区高清视频在线| 91麻豆精品激情在线观看国产| 中国美女看黄片| 国产亚洲精品久久久com| 国内久久婷婷六月综合欲色啪| 国产又黄又爽又无遮挡在线| 国产精品人妻久久久久久| 自拍偷自拍亚洲精品老妇| 舔av片在线| 如何舔出高潮| 婷婷精品国产亚洲av| 久久精品国产自在天天线| 亚洲五月天丁香| 国产精品久久电影中文字幕| 国产精品亚洲美女久久久| 亚洲真实伦在线观看| 亚洲av第一区精品v没综合| 亚洲成a人片在线一区二区| 看黄色毛片网站| 亚洲自拍偷在线| 深爱激情五月婷婷| 少妇熟女欧美另类| 国产成人freesex在线 | 九九热线精品视视频播放| 成年免费大片在线观看| 欧美高清成人免费视频www| 日韩欧美精品v在线| 97在线视频观看| 亚洲成人久久爱视频| 日韩成人伦理影院| 日产精品乱码卡一卡2卡三| 日韩强制内射视频| 极品教师在线视频| 日韩,欧美,国产一区二区三区 | 久久久精品欧美日韩精品| 可以在线观看的亚洲视频| 在线播放无遮挡| 午夜福利在线在线| a级毛片免费高清观看在线播放| 干丝袜人妻中文字幕| 亚洲,欧美,日韩| 久久精品国产亚洲av香蕉五月| 少妇猛男粗大的猛烈进出视频 | 欧美潮喷喷水| 国产高潮美女av| 日韩欧美免费精品| 久久精品国产99精品国产亚洲性色| 看十八女毛片水多多多| 日韩精品有码人妻一区| 亚洲精品影视一区二区三区av| 色哟哟·www| 最近手机中文字幕大全| videossex国产| 一级av片app| 欧美不卡视频在线免费观看| 亚洲一级一片aⅴ在线观看| 给我免费播放毛片高清在线观看| 国产综合懂色| 日日啪夜夜撸| 国产黄色小视频在线观看| 中文字幕人妻熟人妻熟丝袜美| 日本黄色视频三级网站网址| 国内少妇人妻偷人精品xxx网站| 久久久久久国产a免费观看| 久久久久性生活片| 人人妻人人澡人人爽人人夜夜 | 免费一级毛片在线播放高清视频| 五月伊人婷婷丁香| 91在线观看av| 精品午夜福利在线看| 成人鲁丝片一二三区免费| 亚洲欧美精品自产自拍| 欧美日韩乱码在线| 中国美白少妇内射xxxbb| 色吧在线观看| 久久草成人影院| 免费在线观看影片大全网站| 天美传媒精品一区二区| 精品人妻一区二区三区麻豆 | 美女黄网站色视频| 久久久国产成人免费| 亚洲第一区二区三区不卡| 欧美在线一区亚洲| 久久久久免费精品人妻一区二区| av在线观看视频网站免费| 久久九九热精品免费| 日韩成人伦理影院| 国产高清视频在线观看网站| 麻豆乱淫一区二区| 欧美不卡视频在线免费观看| a级毛片a级免费在线| 免费黄网站久久成人精品| 婷婷精品国产亚洲av在线| 亚洲精品影视一区二区三区av| 日韩成人伦理影院| 变态另类丝袜制服| 午夜久久久久精精品| 少妇被粗大猛烈的视频| 精品欧美国产一区二区三| 三级经典国产精品| 成年女人永久免费观看视频| 天堂影院成人在线观看| 久久久午夜欧美精品| 日韩亚洲欧美综合| 国产免费男女视频| 国产男人的电影天堂91| 男人狂女人下面高潮的视频| 欧美日韩综合久久久久久| 嫩草影院新地址| 中文字幕久久专区| 香蕉av资源在线| 国产精品一二三区在线看| 国产高清视频在线播放一区| 亚洲av熟女| 亚洲性久久影院| 亚洲一级一片aⅴ在线观看| 久久人人爽人人片av| 麻豆久久精品国产亚洲av| 国产高清有码在线观看视频| 欧美高清成人免费视频www| 国产成人91sexporn| 色av中文字幕| 我的老师免费观看完整版| 亚洲av熟女| 成人欧美大片| 午夜a级毛片| 精品人妻熟女av久视频| 亚洲欧美日韩东京热| 床上黄色一级片| 久久久久久久亚洲中文字幕| 美女大奶头视频| 在线看三级毛片| 亚洲电影在线观看av| 亚洲婷婷狠狠爱综合网| 日韩在线高清观看一区二区三区| 亚洲内射少妇av| 国内久久婷婷六月综合欲色啪| 18禁黄网站禁片免费观看直播| 成人av在线播放网站| 亚洲中文字幕一区二区三区有码在线看| 校园人妻丝袜中文字幕| 91在线观看av| 亚洲国产欧洲综合997久久,| 乱码一卡2卡4卡精品| 97人妻精品一区二区三区麻豆| 麻豆精品久久久久久蜜桃| 亚洲中文字幕一区二区三区有码在线看| 99久国产av精品国产电影| 不卡视频在线观看欧美| a级毛片a级免费在线| 亚洲人成网站高清观看| 日本色播在线视频| 乱系列少妇在线播放| 99久久久亚洲精品蜜臀av| 女人十人毛片免费观看3o分钟| 一个人看视频在线观看www免费| АⅤ资源中文在线天堂| 久久久精品大字幕| 婷婷六月久久综合丁香| 精品久久久久久成人av| av在线观看视频网站免费| 久久精品国产亚洲网站| 麻豆久久精品国产亚洲av| 午夜精品在线福利| 一个人看的www免费观看视频| 少妇猛男粗大的猛烈进出视频 | 人人妻,人人澡人人爽秒播| av卡一久久| 日韩,欧美,国产一区二区三区 | 亚洲综合色惰| 午夜精品国产一区二区电影 | 免费观看精品视频网站| 欧美bdsm另类| 晚上一个人看的免费电影| 国产 一区精品| 晚上一个人看的免费电影| 中文字幕av成人在线电影| 久久午夜亚洲精品久久| 午夜福利在线观看免费完整高清在 | 日本三级黄在线观看| 婷婷色综合大香蕉| 日韩亚洲欧美综合| 欧美三级亚洲精品| 亚洲aⅴ乱码一区二区在线播放| 一个人看视频在线观看www免费| 成人特级av手机在线观看| av专区在线播放| 我的女老师完整版在线观看| 国产乱人偷精品视频| 亚洲欧美日韩无卡精品| 最新在线观看一区二区三区| 国产高清视频在线播放一区| 国产成人a∨麻豆精品| 18+在线观看网站| 国产精品爽爽va在线观看网站| 老师上课跳d突然被开到最大视频| 国产不卡一卡二| 99久国产av精品国产电影| 亚洲一区二区三区色噜噜| 亚洲va在线va天堂va国产| 国产女主播在线喷水免费视频网站 | 午夜爱爱视频在线播放| 日韩,欧美,国产一区二区三区 | 色播亚洲综合网| 亚洲av五月六月丁香网| 久久久久久国产a免费观看|